Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

96.31
-0.7600-0.78%
Pre-market: 97.000.6900+0.72%07:51 EDT
Volume:731.68K
Turnover:70.51M
Market Cap:6.25B
PE:-6.84
High:97.89
Open:97.65
Low:95.24
Close:97.07
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:1.56
T/O Rate:1.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-600.04
PE(LYR):-204.91

Loading ...

Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Jun 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]